NOV 17, 202655 MINS READ
Creatine phosphate (N-(aminoiminomethyl)-N-methylglycine phosphate; CAS 67-07-2) exists predominantly as the disodium salt dihydrate (C₄H₈N₃O₅P·2Na·xH₂O) in biochemical-grade formulations, with molecular weight approximately 255 Da (anhydrous basis) 512. The molecule features a phosphoamide linkage connecting the guanidinium moiety of creatine to inorganic phosphate, conferring unique chemical reactivity and biological function 29. This high-energy phosphate bond (ΔG°' ≈ -43 kJ/mol) enables reversible phosphoryl transfer to ADP via creatine kinase (CK), maintaining intracellular ATP homeostasis during periods of intense metabolic demand 110.
The biochemical-grade specification mandates rigorous control of impurities, particularly creatine (typically <0.25% w/w) and creatinine (typically <0.1% w/w), which arise from non-enzymatic cyclization and hydrolysis pathways 1617. Advanced HPLC methods employing ion-pairing reagents (e.g., tetrabutylammonium hydrogen sulfate) and UV detection at 205 nm enable quantification of these impurities at sub-ppm levels, ensuring compliance with pharmacopeial standards 16. The disodium salt form exhibits enhanced aqueous solubility (>100 mg/mL at 25°C, pH 7.0–7.5) compared to free acid or lithium salts, facilitating preparation of concentrated stock solutions for enzymatic assays and cell culture supplementation 315.
Structural analogs including phosphorylcyclocreatine and phosphoryl-β-guanidinopropionate have been synthesized as research tools and potential therapeutics, offering altered membrane permeability and CK substrate kinetics 26. The disodium trihydrate form of phosphorylcyclocreatine demonstrates superior solubility (>150 mg/mL) relative to dilithium salts, addressing formulation challenges in parenteral drug development 2.
The enzymatic route represents the gold standard for producing research-grade creatine phosphate, leveraging the reversibility of the creatine kinase reaction 3. This method involves incubating creatine (50–100 mM) with 3-phosphoglyceric acid (equimolar) in the presence of aqueous muscle extract (containing endogenous CK, phosphoglycerate kinase, and adenylate kinase) and catalytic ATP (0.2–2 mM) at pH 8.5–9.0 and 30–37°C 3. The coupled enzyme system regenerates ATP from ADP, driving creatine phosphorylation to >85% conversion within 2–4 hours 3.
Critical process parameters include:
This approach avoids harsh chemical reagents and heavy metal catalysts, yielding product suitable for cell biology and in vivo studies without additional purification 3. However, the requirement for enzyme preparations and ATP limits scalability for industrial production.
Large-scale synthesis employs chemical phosphorylation of creatine or creatinine derivatives 51217. A representative two-step process involves:
Step 1: Creatinine phosphoryl chloride formation
Creatinine (anhydrous, 1 mol) is condensed with phosphorus oxychloride (POCl₃, 45 mol excess) at 105°C under reflux for 30 minutes, yielding creatinine phosphoryl chloride as a viscous intermediate 5. Excess POCl₃ is removed by vacuum distillation (<50 mmHg, 30–40°C), and the residue is dissolved in dichloromethane (10 volumes) to precipitate insoluble byproducts 5. Addition of petroleum ether (2 volumes) induces crystallization of purified creatinine phosphoryl chloride (mp 78–82°C, yield 75–80%) 5.
Step 2: Alkaline hydrolysis and ring-opening
The phosphoryl chloride intermediate (1 mol) is hydrolyzed in aqueous NaOH (4–4.5 mol, 20% w/v) at 0–5°C over 1–2 hours, forming the cyclic creatinine phosphate sodium salt 512. Subsequent heating to 80°C for 15 minutes in additional NaOH (pH >12) opens the imidazolidinone ring, generating creatine phosphate disodium salt 12. Neutralization with glacial acetic acid to pH 8.0–9.0, followed by ethanol precipitation (2.5 volumes) and recrystallization, affords product with HPLC purity ≥99.0% and yield 65–70% (based on creatinine) 512.
An alternative single-step route directly phosphorylates creatine monohydrate with 98% phosphoric acid in methanol or ethanol at 50–60°C, achieving 89–91% molar yield and ≥99.8% purity without chromatographic purification 17. This green chemistry approach eliminates halogenated solvents and enables solvent recovery by distillation, reducing waste generation and production costs 17.
Biochemical-grade creatine phosphate must meet stringent specifications:
Ion-pair reversed-phase HPLC using C₁₈ columns (250 × 4.6 mm, 5 μm) with mobile phases containing tetrabutylammonium hydrogen sulfate (0.78 g/L) and 5% NaCl (pH 7.0, adjusted with H₃PO₄) provides baseline resolution of creatine phosphate, creatine, and creatinine within 15 minutes 16. UV detection at 205 nm enables quantification down to 0.25 μg/mL (LOQ), supporting impurity profiling at 0.05% levels 16.
Creatine phosphate disodium salt exhibits high aqueous solubility (>250 mg/mL at 25°C, pH 7.2), enabling preparation of concentrated stock solutions (0.5–1.0 M) for enzymatic assays and cell culture experiments 315. However, aqueous solutions undergo spontaneous hydrolysis to creatine and inorganic phosphate, with kinetics strongly pH- and temperature-dependent 15. At pH 7.4 and 25°C, the pseudo-first-order degradation rate constant is approximately 0.002 h⁻¹ (t₁/₂ ≈ 350 hours), accelerating to 0.015 h⁻¹ at 37°C (t₁/₂ ≈ 46 hours) 15.
Stabilization strategies include:
Lyophilized powder stored in sealed containers under inert atmosphere (nitrogen or argon) at −20°C remains stable for >3 years, with <2% degradation as assessed by HPLC 512.
Creatine phosphate exhibits weak UV absorption (λmax ≈ 205 nm, ε ≈ 1,200 M⁻¹cm⁻¹ in water), necessitating sensitive detection methods for quantification 16. The compound shows no significant fluorescence, limiting applicability of fluorometric assays 16. Infrared spectroscopy reveals characteristic bands at 1650 cm⁻¹ (C=N stretch), 1200 cm⁻¹ (P=O stretch), and 1050 cm⁻¹ (P–O stretch), confirming phosphoamide linkage integrity 5.
Thermogravimetric analysis (TGA) of the dihydrate form shows initial mass loss (7–9%) at 80–120°C corresponding to dehydration, followed by decomposition onset at 180–200°C with exothermic decomposition peaking at 240–260°C 5. Differential scanning calorimetry (DSC) indicates no distinct melting point, consistent with decomposition preceding melting 5.
The phosphoamide bond in creatine phosphate is susceptible to nucleophilic attack by water, hydroxide ions, and primary amines, leading to phosphoryl transfer or hydrolysis 915. Under alkaline conditions (pH >9), the rate of hydrolysis increases exponentially, with complete degradation occurring within hours at pH 11 and 37°C 12. Conversely, acidic conditions (pH <5) promote cyclization to creatinine phosphate, which subsequently hydrolyzes to creatinine and phosphate 5.
Enzymatic degradation by alkaline phosphatase (ubiquitous in biological samples) represents a major concern in cell culture and tissue homogenate studies, necessitating inclusion of phosphatase inhibitors (e.g., sodium orthovanadate, 1 mM; sodium fluoride, 10 mM) in experimental buffers 110.
Creatine phosphate serves as the primary substrate for reverse creatine kinase reactions in clinical diagnostics and enzymology research 10. The CK-MB isoenzyme assay, critical for myocardial infarction diagnosis, employs creatine phosphate (≥2 mM) and ADP (0.5–1.0 mM) in the presence of immunoinhibitory antibodies against CK-M subunits, enabling specific quantification of CK-MB activity via coupled enzymatic detection of ATP production 10. Analytical elements incorporating creatine phosphate at coating densities of 1–2 g/m² provide rapid (<5 minutes) point-of-care testing with detection limits <5 U/L 10.
Kinetic studies of CK isoforms require high-purity creatine phosphate to avoid interference from adenylate kinase (AK), which catalyzes the reaction 2 ADP ↔ ATP + AMP 10. Inclusion of P¹,P⁵-di(adenosine-5')pentaphosphate (DAPP, 50–100 μM) as a competitive AK inhibitor, combined with excess AMP (≥10-fold molar excess over ADP), suppresses AK activity by >95%, ensuring accurate CK-MB quantification even in liver homogenates with high AK-1 levels 10.
Exogenous creatine phosphate supplementation (5–20 mM) in isolated cell systems and perfused organs maintains ATP/ADP ratios during ischemic stress, enabling investigation of energy-dependent processes under controlled metabolic conditions 17. In brain tissue studies, creatine phosphate levels (quantified by enzymatic cycling assays or ³¹P-NMR spectroscopy) serve as biomarkers of bioenergetic status during hypoxia, with concentrations declining from 4–6 μmol/g wet weight (normoxia) to <1 μmol/g after 30 minutes of circulatory arrest 1.
Mathematical modeling of the creatine kinase/phosphocreatine system utilizes experimentally determined ATP and AMP concentrations to calculate intracellular creatine phosphate levels via equilibrium relationships (Keq ≈ 160 at pH 7.0, 25°C, ionic strength 0.25 M) 1:
[PCr] = Keq × [ATP] × [Cr] / ([ADP] × [H⁺])
This approach enables non-invasive estimation of phosphocreatine dynamics in tissues where direct measurement is technically challenging 1.
Biochemical-grade creatine phosphate is indispensable for characterizing phosphotransferases, ATPases, and kinases in vitro 3. Steady-state kinetic analysis of creatine kinase isoforms requires substrate concentrations spanning 0.1–10× Km values (typically 0.5–5 mM for creatine phosphate), necessitating high-purity reagents to achieve accurate Michaelis-Menten parameters 10. Pre-steady-state kinetic experiments employing rapid-mixing techniques (stopped-flow, quench-flow) demand creatine phosphate solutions with <0.1% ADP contamination to avoid burst-phase artifacts 3.
Isotope exchange studies using [γ-¹⁸O₄]phosphocreatine (synthesized from creatine and H₃¹⁸PO₄) elucidate phosphoryl transfer mechanisms and transition state structures in CK-catalyzed reactions, providing insights into enzyme evolution and inhibitor design 23.
Creatine phosphate has been investigated as a cardioprotective agent in myocardial ischemia, with clinical formulations (e.g., Neoton®) administered intravenously at doses of 1–2 g (4–8 mmol) per day 9. The rationale centers on replenishing depleted high-energy phosphate pools, thereby preserving ATP-dependent ion pumps (Na⁺/K⁺-ATPase, Ca²⁺-ATPase) and mitigating calcium overload during reperfusion 79. Preclinical studies in rat models demonstrate that intra
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| BOEHRINGER MANNHEIM GMBH | Large-scale biochemical-grade creatine phosphate production for research applications in bioenergetics, enzymology, and pharmaceutical development requiring high-purity reagents. | Enzymatic Creatine Phosphate Synthesis System | Achieves >85% conversion of creatine to creatine phosphate within 2-4 hours using coupled enzyme system with muscle extract, ATP regeneration, and pH maintenance at 8.5±0.2, yielding >95% purity after single ethanol recrystallization. |
| EASTMAN KODAK COMPANY | Clinical diagnostics for myocardial infarction detection through creatine kinase-MB isoenzyme assays in hospital emergency departments and cardiac care units. | CK-MB Diagnostic Analytical Element | Incorporates creatine phosphate at 1-2 g/m² coating density with P1,P5-di(adenosine-5')pentaphosphate (50-100 μM) to suppress adenylate kinase interference by >95%, enabling rapid (<5 minutes) point-of-care CK-MB quantification with detection limits <5 U/L. |
| XENOPORT INC. | Therapeutic treatment of ischemia-reperfusion injury, heart failure, neurodegenerative disorders, and energy metabolism diseases requiring intracellular high-energy phosphate replenishment. | Membrane Permeable Creatine Phosphate Prodrugs | Develops membrane-permeable prodrug formulations of creatine phosphate and analogs (including phosphorylcyclocreatine disodium trihydrate with >150 mg/mL solubility) to enhance cellular uptake and maintain ATP homeostasis during metabolic stress. |
| ZHONGSHAN BELLING BIOTECHNOLOGY CO. LTD. | Pharmaceutical manufacturing and biochemical research requiring stringent quality control for cell culture supplementation, enzymatic assays, and therapeutic formulations in cardioprotection applications. | High-Purity Creatine Phosphate Disodium Salt (≥99% HPLC) | Chemical synthesis route via creatinine phosphoryl chloride intermediate followed by alkaline hydrolysis achieves ≥99.0% purity with 65-70% yield, meeting pharmaceutical-grade specifications with creatine <0.25% and creatinine <0.1%, validated by ion-pair HPLC at 205 nm detection. |